John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFS
676
DELISTED
Discover Financial Services
DFS
| $4.81M | 0.02% |
89,722
-1,273,196
| -93% | -$70.6M |
|
677
Nice
NICE
$5.86B
| $4.81M | 0.02% |
83,898
+47,668
| +132% | +$2.84M |
|
678
Popular Inc
BPOP
$10.9B
| $4.8M | 0.02% |
+169,500
| New | +$5.01M |
|
|
RP
679
DELISTED
RealPage, Inc.
RP
| $4.78M | 0.02% |
+213,038
| New | +$4.33M |
|
680
Qualys
QLYS
$6.28B
| $4.76M | 0.02% |
143,963
-171,037
| -54% | -$6.03M |
|
681
HEICO Corp
HEI
$49.4B
| $4.76M | 0.02% |
213,730
-165,328
| -44% | -$3.44M |
|
682
Ternium
TX
$11B
| $4.76M | 0.02% |
382,764
+290,110
| +313% | +$4.05M |
|
683
Thor Industries
THO
$4.17B
| $4.75M | 0.02% |
84,649
-34,800
| -29% | -$1.93M |
|
684
Apple
AAPL
$4.54T
| $4.74M | 0.02% |
180,204
-2,924,452
| -94% | -$83.6M |
|
|
IMS
685
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $4.72M | 0.02% |
185,304
-118,340
| -39% | -$3.31M |
|
|
AAT
686
American Assets Trust
AAT
$1.41B
| $4.7M | 0.02% |
122,437
+99,180
| +426% | +$4.02M |
|
687
Texas Instruments
TXN
$239B
| $4.65M | 0.02% |
84,908
-912,207
| -91% | -$50.9M |
|
688
Benchmark Electronics
BHE
$2.57B
| $4.65M | 0.02% |
225,064
+165,435
| +277% | +$3.5M |
|
689
CALL
American International
AIG
$40.4B
| $4.65M | 0.02% |
75,000
+65,000
| +650% | +$3.96M |
|
690
MetLife
MET
$60.7B
| $4.65M | 0.02% |
108,163
+19,582
| +22% | +$861K |
|
691
Targa Resources
TRGP
$63.5B
| $4.63M | 0.02% |
+171,225
| New | +$7.6M |
|
|
CVA
692
DELISTED
Covanta Holding Corporation
CVA
| $4.63M | 0.02% |
+299,118
| New | +$4.89M |
|
693
FS KKR Capital
FSK
$3.29B
| $4.59M | 0.02% |
127,590
+34,970
| +38% | +$1.35M |
|
694
Oaktree Specialty Lending
OCSL
$1.14B
| $4.58M | 0.02% |
239,271
+96,893
| +68% | +$1.79M |
|
695
AMN Healthcare
AMN
$1.34B
| $4.57M | 0.02% |
147,149
-173,965
| -54% | -$5.15M |
|
|
CTCT
696
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $4.57M | 0.02% |
+156,184
| New | +$4.51M |
|
697
Broadridge
BR
$20.9B
| $4.56M | 0.02% |
84,826
-259,957
| -75% | -$14.6M |
|
698
PUT
Baxter International
BAX
$13.6B
| $4.54M | 0.02% |
+119,000
| New | +$4.35M |
|
699
Novartis
NVS
$299B
| $4.52M | 0.02% |
58,592
-243,378
| -81% | -$19.3M |
|
|
SYA
700
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $4.5M | 0.02% |
141,695
+117,875
| +495% | +$3.73M |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.